Delhi: Varco Leg Care has announced raising a bridge funding round of Rs 2 crore to advance its mission of revolutionising leg care across India and the world. This round was led by Neeraj Garg, Former CEO, Hindustan Coca-Cola. Besides the participation of existing investors, the round also witnessed participation from multiple new investors, including senior executives from Coca-Cola, Emporia UAE, Highway Concessions One – a KKR company, and a few HNIs.
The company will be utilising the newly acquired capital to propel the company’s growth across various crucial areas, such as the acquisition of top talent, expanding its retail presence, appointing key opinion leaders (KOLs), exploring new international markets, integrating cutting-edge technology to enhance treatment adherence, enhancing R&D efforts, and elevating customer retention efforts.
Speaking about the latest fundraise, Anondeep Ganguly, CEO, Varco Leg Care remarked, “Additionally, the funding will play a major role in bolstering our mission of fostering a healthier, happier world, one leg at a time. In the long run, we aim to become a global leader in the leg care solutions domain, and envision a world where all individuals move freely without any leg disorder burdens.”
Garg said, “This successful fundraise underscores the profound belief that investors have in Varco Leg Care. Going forward, we foresee Varco Leg Care products becoming a household essential across our country and internationally too.”
The start-up is determined to achieve 10x growth in its monthly recurring revenue (MRR). This transformation shall be driven by several key initiatives, including attracting top-notch experts to strengthen its team, integrating technology into operations for streamlining procedures and enhancing client experiences, and ensuring that the company remains at the forefront of innovation and excellence. Furthermore, Varco will also be expanding its product portfolio, introducing unique topical phyto products for foot ulcers, restless leg syndrome, nail fungus and cellulite.
The company is actively developing a comprehensive leg care products portfolio and plans to strengthen its position across the US market through strategic partnerships with leading marketplaces, as well as to expand to new markets such as GCC countries.
